Oct 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2023 Sep 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.49 2.51 5.20
(-1.0 pct) (+7.8 pct) (+5.6 pct)
Operating 517 mln 511 mln 850 mln
(+1.3 pct) (+15.6 pct) (+3.5 pct)
Recurring 525 mln 527 mln 850 mln
(-0.4 pct) (+18.7 pct) (-0.5 pct)
Net 370 mln 358 mln 570 mln
(+3.1 pct) (+19.2 pct) (+0.3 pct)
EPS 88.66 yen 85.99 yen 136.56 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T